SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-151704
Filing Date
2021-05-05
Accepted
2021-05-05 16:07:28
Documents
60
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d172290d10q.htm 10-Q 377839
2 EX-31.1 d172290dex311.htm EX-31.1 11181
3 EX-31.2 d172290dex312.htm EX-31.2 11227
4 EX-32.1 d172290dex321.htm EX-32.1 6273
  Complete submission text file 0001193125-21-151704.txt   3275845

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT dbvt-20210331.xml EX-101.INS 685386
6 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20210331.xsd EX-101.SCH 37845
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dbvt-20210331_cal.xml EX-101.CAL 37546
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20210331_def.xml EX-101.DEF 186402
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20210331_lab.xml EX-101.LAB 285984
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20210331_pre.xml EX-101.PRE 240137
Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36697 | Film No.: 21893256
SIC: 2836 Biological Products, (No Diagnostic Substances)